ARCHIVES

Tamoxifen Trial may EB Funded In Part With CCOP Money

This article is from The Cancer Letter archive.

Vol. 17 No. 12 | March 22, 1991

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Concepts Of Eight New Biological Response Modifiers Program

July 3, 1981

Paulette Gray named director of NCI Division of Extramural Activities.

April 22, 2005

Grants Funding: R01 Payline To tighten To 22nd Percentile This Year, NCI Says.

November 29, 1996

Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial

July 25, 2014

AACR honors Emil Frei III for pioneering work in childhood leukemia.

April 2, 2004

NEJM Paper Ignites Debate Over Spiral CT Scans For Lung Cancer.

November 3, 2006